Carmine Therapeutics Company Profile, Contacts & Intelligence
Carmine Therapeutics Overview
Carmine Therapeutics, headquartered in Cambridge MA, is pioneering a new class of non-viral gene therapies based on red blood cell extracellular vesicles, combined with proprietary payloads. In June 2020, Carmine inked a research alliance with Takeda Pharmaceuticals worth up to $900 million to develop non-viral gene therapies for 2 targets. Carmine has also been named one of the FierceBiotech’s Fierce 15 Biotech companies of 2020 and was also awarded the Bristol-Myers Squibb "Golden Ticket". Carmine was founded in 2019 by EVX Ventures, Professors Harvey Lodish (Whitehead, MIT), Minh Le and Jiahai Shi. Professor Lodish, who was a founding member of several successful biotech companies that include Genzyme and Millennium Pharmaceuticals, is also Chair of the Scientific Advisory Board of Carmine. For more information, visit www.carminetherapeutics.com Media Relations Media@carminetherapeutics.com Investor Relations Investors@carminetherapeutics.com
- Headquarters
- 700 Main St
- Website
- carminetherapeutics.com
- Industry
- Biotechnology Research
- Founded
- 2019
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology)
- Company Email
- Available in AeroLeads
Carmine Therapeutics Contact Intelligence
See which contact channels and departments are represented in the visible AeroLeads data.
Carmine Therapeutics People & Org Chart Preview
Sample people records show job titles and whether email or phone data is available without exposing raw contact details.
Carmine Therapeutics Workforce Composition
Seniority breakdown across 9 visible profiles.
Compare Similar Companies to Carmine Therapeutics
Explore companies in related markets and compare their industry and employee estimates.
| Company | Industry / match | Employee estimate | Page |
|---|---|---|---|
| Esco | Biotechnology Research | 1.22K | View company |
| Nimbus Therapeutics | Biotechnology Research | 106 | View company |
| Acrivon Therapeutics, Inc. | Biotechnology Research | 80 | View company |
| HiFiBiO Therapeutics | Biotechnology | 56 | View company |
| Ascidian Therapeutics | Biotechnology | 47 | View company |
| Nuevocor | Biotechnology Research | 31 | View company |
| Acer Therapeutics Inc. | Pharmaceutical Manufacturing | 10 | View company |
| Carcell Biopharma | Biotechnology Research | 8 | View company |
| Lerna Biopharma | Biotechnology Research | 4 | View company |
| Casebia Therapeutics | Biotechnology | Not listed | View company |